Home / Health / New 'Orphine' Opioid Found in Toronto Fentanyl
New 'Orphine' Opioid Found in Toronto Fentanyl
19 Nov
Summary
- A novel orphine-class opioid, N'-Phenethyl-5-chloro nor-orphine, detected in Toronto.
- The unknown drug's potency and effects remain largely unresearched.
- Fentanyl samples in Toronto are heavily cut with other drugs, including tranquilizers.
A novel orphine-class opioid, currently lacking a generic name, has been identified in fentanyl samples in Toronto. This discovery, also noted in Vancouver, represents the sixth new substance found in Toronto's illicit drug supply this year. Experts express concern over the unknown potency and effects of this designer drug, as research is scarce. The substance is chemically similar to N'-Phenethyl-5-chloro nor-orphine and N'-Phenethyl-6-chloro nor-orphine.
The contamination of street drugs is a significant issue, with 96% of fentanyl samples in Toronto found to be mixed with non-opioid substances like veterinary tranquilizers or benzodiazepines. Furthermore, 83% contained multiple high-potency opioids, and over a quarter included a combination of high-potency opioids, tranquilizers, and benzodiazepines. This complex mixture contributes to the rise in overdose deaths involving multiple substances across Canada.
Drug market dynamics, influenced by precursor chemical availability and law enforcement strategies, drive the constant evolution of street drug compositions. Producers aim to create potent, cost-effective substances, leading to a cycle of introduction, testing, and market adjustment. The emergence of 'ultra-potent' opioids like orphines highlights the ongoing challenges in controlling these unpredictable markets.